Study guide
5.1 The Four-Step Cleaning Process
PTCB Hazardous Drug Management Certificate Exam
Track your progress as you read
Finished sections get a check mark.
1 Introduction & Exam Overview
0.1 Exam Facts, Format & Eligibility 0.2 Content Outline, Scoring & Registration 0.3 USP <800> Big Picture & How to Use This Guide
2 USP <800> Program Administration
1.1 USP <800> Scope, Purpose & Enforcement 1.2 The NIOSH Hazardous Drug List (2024 Update) 1.3 Assessment of Risk 1.4 Designated Person, SOPs & the Hierarchy of Controls
3 Training, Compliance & Recordkeeping
2.1 Training Requirements & Medical Surveillance 2.2 Hazard Communication, SDS & OSHA Requirements 2.3 Recordkeeping & Professional Guidelines
4 Primary Engineering Controls
3.1 Containment Primary Engineering Controls (C-PEC): BSCs & CACIs 3.2 Closed System Transfer Devices (CSTDs) 3.3 Nonsterile Controls and the C-SCA Distinction
5 Secondary Engineering Controls & Facility Design
4.1 Containment Secondary Engineering Controls (C-SEC): Negative Pressure & Air Exchange 4.2 Facility Layout: Storage, Unpacking & Sink Placement 4.3 Certification, ISO Classes & Emergency Equipment
6 Facility Cleaning Procedures
5.1 The Four-Step Cleaning Process 5.2 Wipe Sampling & Action Levels 5.3 Hazardous Waste Disposal & RCRA
7 Spill Response & Cleaning PPE
6.1 Spill Kits & Spill Response Procedures 6.2 PPE During Cleaning: Glove Change Frequency & Disposal
8 Dispensing & the Compounding Interface
7.1 USP <795>/<797> Interface for Hazardous Drugs 7.2 High-Risk Oral Hazardous Drugs 7.3 Tablet Splitting & Crushing Restrictions
9 Counting, Packaging & Patient Counseling
8.1 Counting, Packaging & Dedicated Equipment 8.2 Patient Counseling & Unit-Dose Labeling
10 PPE: Gloves, Gowns & Task-Based Selection
9.1 ASTM D6978 Chemotherapy Gloves & Double Gloving 9.2 Chemo Gowns & Gown Change Frequency 9.3 Task-Based PPE Selection
11 Respiratory Protection, Eye Protection & PPE Sequencing
10.1 Respiratory & Eye/Face Protection 10.2 Donning & Doffing Sequence
12 Transport & Receiving
11.1 Receiving Hazardous Drug Shipments 11.2 Internal Transport & Storage 11.3 Damaged/Leaking Shipments & Chain of Custody
13 Exam Readiness & Final Review
12.1 Domain-by-Domain Quick Review 12.2 Common Exam Traps & Final Checklist
5.1 The Four-Step Cleaning Process
Key Takeaways Explain This Topic AI
USP <800> requires four sequential cleaning steps for hazardous drug areas: deactivation (chemically alters the HD), decontamination (physically removes residue), cleaning (removes organic/inorganic material with germicidal detergent), and disinfection (reduces microorganisms in ISO-classified sterile areas)
Not every hazardous drug has a validated deactivating agent; when none exists, personnel proceed directly to decontamination, cleaning, and disinfection without reordering the remaining steps
C-PEC work surfaces must be cleaned at the beginning of each shift, before and after each batch, every 30 minutes during continuous compounding, after a spill, and whenever contamination is known or suspected
C-SEC floors require cleaning at least daily; less-frequently touched surfaces such as walls, ceilings, and storage shelving follow a defined periodic schedule such as monthly
Cleaning with a germicidal detergent is required even where no HD residue is present, as part of routine environmental cleaning
Last updated: July 2026
The Four-Step Cleaning Process
Facility Cleaning makes up 16% of the PTCB Hazardous Drug Management Certificate exam, and the four-step cleaning process required by USP <800> is the centerpiece of this domain. Compounding personnel who handle hazardous drugs (HDs) must understand not just that surfaces get "cleaned," but that four distinct, sequential steps are required -- and that skipping or reordering them fails to protect staff and patients from HD residue.
Why Four Separate Steps?
Hazardous drug residue is different from ordinary microbial or particulate contamination. A surface can look spotless and still carry enough cyclophosphamide or other cytotoxic residue to pose a reproductive or carcinogenic risk to compounding staff. USP <800> therefore requires a layered approach: first neutralize the chemical hazard, then physically remove it, then clean the surface the way any compounding area must be cleaned, and finally disinfect where sterility matters.
- The Four Steps
- 1. Deactivation
Deactivation chemically alters the hazardous drug into a less hazardous or inactive form. Oxidizer-based agents -- such as sodium hypochlorite (bleach) solutions or peroxide-based products -- are the most commonly used deactivating agents because oxidation breaks down many cytotoxic molecules. A critical exam trap: not every hazardous drug has a validated deactivating agent. For HDs without one, personnel move directly to decontamination, cleaning, and disinfection, relying on physical removal rather than chemical neutralization.
2. Decontamination
Decontamination physically removes HD residue from a surface using mechanical action -- wiping with water or isopropyl alcohol (IPA) combined with friction. Decontamination does not chemically change the drug; it relies on solubility and physical wiping to transfer residue off the surface and into a wipe or waste container.
3. Cleaning
Cleaning removes organic and inorganic material (dust, oils, packaging residue) using a germicidal detergent. This step is required as part of routine environmental cleaning even in areas where no HD residue is present or suspected -- it is a baseline sanitation requirement, not solely an HD-specific step.
4. Disinfection
Disinfection reduces the number of microorganisms on a surface and is required specifically for ISO-classified sterile compounding areas (C-PECs and the certified portions of the C-SEC used for sterile HD compounding). Sterile 70% isopropyl alcohol is commonly used, and a sporicidal agent must be applied on a defined schedule to control spore-forming organisms that IPA alone cannot kill.
Step Purpose Typical Agent Chemically Alters HD?
- Deactivation Convert HD to less hazardous form Sodium hypochlorite, peroxide-based agents Yes
- Decontamination Physically remove HD residue Water or IPA + mechanical wiping No
- Cleaning Remove organic/inorganic material Germicidal detergent No
- Disinfection Reduce microorganisms Sterile 70% IPA, sporicidal agent No
- Cleaning Frequency
USP <800> ties cleaning frequency to how contaminated a surface is likely to become:
Location Minimum Frequency
C-PEC (BSC, CACI work surfaces) Beginning of each shift, before and after each batch, every 30 minutes during continuous compounding, after a spill, and whenever contamination is known or suspected
C-SEC floors At least daily
Walls, ceilings, storage shelving (less-frequently touched surfaces) Defined periodic schedule (e.g., monthly), per facility SOP
Notice that the C-PEC -- the primary engineering control where the technician's hands and the drug vial are in closest contact -- has by far the most demanding schedule, including the "every 30 minutes during continuous compounding" rule, which exam writers frequently test.
Documenting Cleaning
USP <800> ties cleaning to the facility's broader quality assurance program, so cleaning events are not just performed -- they are recorded. A cleaning log typically captures the date and time cleaning was performed, the specific area or surface (e.g., "CACI work surface," "C-SEC floor"), which of the four steps were completed, and the initials of the trained personnel who performed the cleaning. This log serves two purposes on the exam and in practice: it demonstrates the required frequency was actually met (not just planned), and it becomes the evidence reviewed if a later wipe sample or spill investigation needs to trace back what cleaning occurred and when. A facility that can show cleaning was performed on schedule but still returns an elevated wipe sample result has a very different corrective-action path than one that cannot produce a log at all.
Order Matters
Exam questions often test whether you know the correct sequence -- performing disinfection before decontamination would leave HD residue behind that a disinfectant is not designed to remove, and it would defeat the purpose of the physical-removal steps. The safe sequence is always deactivate, then decontaminate, then clean, then disinfect. If a validated agent for a required step doesn't exist for a given drug (most often deactivation), that individual step is skipped -- but the remaining steps are never reordered to compensate.
Exam Scenario
A pharmacy technician has just finished compounding a batch of cyclophosphamide in the CACI. Before starting the next unrelated sterile (non-HD) batch, what must happen to the work surface? The technician must perform all applicable steps in the C-PEC: deactivate the cyclophosphamide residue with an appropriate oxidizing agent (since a validated deactivating agent exists for cyclophosphamide), decontaminate with IPA and mechanical wiping, clean with a germicidal detergent, and disinfect with sterile 70% IPA before compounding the next sterile preparation -- because the CACI is an ISO-classified sterile compounding area where disinfection is mandatory regardless of whether the next batch involves a hazardous drug.